With An Additional Active Ingredient Patents (Class 514/537)
  • Patent number: 4942175
    Abstract: A composition suitable for use in the aversion therapy treatment of cocaine abuse. The composition has the physical characteristics, taste, and anesthetic effect similar to cocaine. The composition comprises an amount of a local anesthetic sufficient to induce a degree of anesthesia similar to that induced by cocaine. The composition further comprises a carrier compound possessing the physical characteristics of cocaine. The composition may further comprise additional components which aid in imparting the physical characteristics, odor, taste, or anesthetic effect of cocaine to the composition of the present invention.
    Type: Grant
    Filed: April 24, 1987
    Date of Patent: July 17, 1990
    Assignee: Schick Laboratories, Inc.
    Inventor: Patrick J. Frawley, III
  • Patent number: 4861758
    Abstract: Coccidiocidal compositions which contain the polyether antibiotic maduramicin or its salt in combination with one or more active substances from the group comprising meticlorpindol methyl benzoquate, amprolium, beclotiamine or halofuginone or its salts show synergistic effects.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: August 29, 1989
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Wolfgang Raether
  • Patent number: 4859703
    Abstract: Single dose formulations containing a combination of a lipid regulating agent selected from gemfibrozil, clofibrate, bezafibrate, or fenofibrate and an ACAT inhibiting agent are effective pharmacological formulations for regulating blood serum lipid and cholesterol levels.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: August 22, 1989
    Assignee: Warner-Lambert Company
    Inventor: Brian R. Krause
  • Patent number: 4855299
    Abstract: Coccidiocidal agents which contain the polyether antibiotic monensin or its salt in combination with one or more active substances from the group comprising methyl benzoquate, nicarbazin, amprolium, beclotiamine or halofuginone or its salts show synergistic effects.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: August 8, 1989
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Wolfgang Raether
  • Patent number: 4824847
    Abstract: Coccidiocidal compositions which contain the polyether antibiotic lasalocid A or its salt or ester in combination with one or more active substances from the group comprising meticlorpindol, methyl benzoquate, nicarbazin, amprolium, beclotiamine or halofuginone or its salts show synergistic effects.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: April 25, 1989
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Wolfgang Raether
  • Patent number: 4656163
    Abstract: The present invention relates to the use of the sulphenic acid amides of the general formula (I) ##STR1## in which X represents identical or different halogen atoms,Y.sup.1 and Y.sup.2 are identical or different and represent hydrogen, halogen, alkyl, alkoxy, halogenoalkyl or NO.sub.2 andZ represents halogen, --OH, --NHOH or the group --OR.sup.1,in whichR.sup.1 denotes optionally substituted radicals from the series comprising alkyl, alkenyl, alkinyl, cycloalkyl, aryl, aralkyl and heterocyclyl, orZ represents the group ##STR2## in which R.sup.2 and R.sup.3 are identical or different and denote hydrogen or a heterocyclic radical, orZ represents the group --OMin which M denotes ammonium or the equivalent of an alkali metal, alkaline earth metal or heavy metal cation, for prolonging the duration of a high activity in agents for combating soil pests.
    Type: Grant
    Filed: November 14, 1985
    Date of Patent: April 7, 1987
    Assignees: Bayer Aktiengesellschaft, Mobay Corporation
    Inventors: John Anderson, Bernhard Homeyer, Engelbert Kuhle, Hans Scheinpflug, Walter M. Zeck, Donald E. Simonet
  • Patent number: 4594357
    Abstract: The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension agents are glycerides and/or esters of mono- or poly-hydric alcohols as well as selected ethers, alcohols and amides.
    Type: Grant
    Filed: June 20, 1984
    Date of Patent: June 10, 1986
    Assignee: Troponwerke GmbH & Co.
    Inventors: Hans-Dieter Dell, Bernhard Pelster, Reinhold Kraus, Detlef Schierstedt